Literature DB >> 1302873

Mutant vasopressin precursor producing cells of the homozygous Brattleboro rat as a model for co-expression of neuropeptides.

F W van Leeuwen1.   

Abstract

The homozygous Brattleboro rat (di/di) synthesizes a VP precursor with an abnormal C terminus, which is not transported from the rough endoplasmic reticulum to the Golgi apparatus. In addition, the phenotypic expression of co-existing peptides is differentially disturbed. Ang II and 7B2 are two of the peptides which are not detectable, whereas other peptides (e.g. galanin) are clearly expressed in mutant VP cells. During postnatal life a small but increasing number of solitary post-mitotic VP neurons of the di/di rat undergoes a switch to a heterozygous phenotype. At the same time Ang II and 7B2 show up again in these heterozygous cells, which suggests that for the expression of 7B2, but not for that of other peptides (e.g. galanin), a normal VP precursor is required. A possible underlying mechanism (i.e. the existence of several domains on the endoplasmic reticulum involved in the translocation of sets of neuropeptides) for this differential phenotypic expression of co-existing peptides is discussed.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1302873     DOI: 10.1016/s0079-6123(08)61171-1

Source DB:  PubMed          Journal:  Prog Brain Res        ISSN: 0079-6123            Impact factor:   2.453


  2 in total

Review 1.  Neuroendocrine secretory protein 7B2: structure, expression and functions.

Authors:  M Mbikay; N G Seidah; M Chrétien
Journal:  Biochem J       Date:  2001-07-15       Impact factor: 3.857

2.  Cellular and subcellular evidence for neuronal interaction between the chemokine stromal cell-derived factor-1/CXCL 12 and vasopressin: regulation in the hypothalamo-neurohypophysial system of the Brattleboro rats.

Authors:  Céline Callewaere; Brigitte Fernette; Danièle Raison; Patricia Mechighel; Arlette Burlet; André Calas; Patrick Kitabgi; Stéphane Mélik Parsadaniantz; William Rostène
Journal:  Endocrinology       Date:  2007-09-27       Impact factor: 4.736

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.